Modulation of Secondary Cancer Risks from Radiation Exposure by Sex, Age and Gonadal Hormone Status: Progress, Opportunities and Challenges
Open Access
- 30 April 2022
- journal article
- review article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (5) , 725
Abstract
Available data on cancer secondary to ionizing radiation consistently show an excess (2-fold amount) of radiation-attributable solid tumors in women relative to men. This excess risk varies by organ and age, with the largest sex differences (6- to more than 10-fold) found in female thyroid and breasts exposed between birth until menopause (~50 years old) relative to age-matched males. Studies in humans and animals also show large changes in cell proliferation rates, radiotracer accumulation and target density in female reproductive organs, breast, thyroid and brain in conjunction with physiological changes in gonadal hormones during the menstrual cycle, puberty, lactation and menopause. These sex differences and hormonal effects present challenges as well as opportunities to personalize radiation-based treatment and diagnostic paradigms so as to optimize the risk/benefit ratios in radiation-based cancer therapy and diagnosis. Specifically, Targeted Radionuclide Therapy (TRT) is a fast-expanding cancer treatment modality utilizing radiopharmaceuticals with high avidity to specific molecular tumor markers, many of which are influenced by sex and gonadal hormone status. However, past and present dosimetry studies of TRT agents do not stratify results by sex and hormonal environment. We conclude that cancer management using ionizing radiation should be personalized and informed by the patient sex, age and hormonal status.Keywords
Funding Information
- Stony Brook University Undergraduate Research and Creative ctivities (URECA)
This publication has 144 references indexed in Scilit:
- Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort studyThe Lancet, 2012
- Cancer risk related to low-dose ionizing radiation from cardiac imaging in patients after acute myocardial infarctionCanadian Medical Association Journal, 2011
- Risk of Second Primary Thyroid Cancer after Radiotherapy for a Childhood Cancer in a Large Cohort Study: An Update from the Childhood Cancer Survivor StudyRadiation Research, 2010
- Exposure to Low-Dose Ionizing Radiation from Medical Imaging ProceduresNew England Journal of Medicine, 2009
- Radiation Dose and Breast Cancer Risk in the Childhood Cancer Survivor StudyJournal of Clinical Oncology, 2009
- Long-term Outcomes in Survivors of Neuroblastoma: A Report From the Childhood Cancer Survivor StudyJNCI: Journal of the National Cancer Institute, 2009
- Sex Differences in Pharmacokinetics and PharmacodynamicsClinical Pharmacokinetics, 2009
- Assessment of Human Biodistribution and Dosimetry of 4-Fluoro-11β-Methoxy-16α-18F-Fluoroestradiol Using Serial Whole-Body PET/CTJournal of Nuclear Medicine, 2008
- Variation of Breast Cancer Risk Among BRCA1/2 CarriersJAMA, 2008
- Involvement of estrogen receptor β in terminal differentiation of mammary gland epitheliumProceedings of the National Academy of Sciences, 2002